Clinical trial
A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of…
NCT00119600 · Amgen, Industry · Terminated
Key facts
| NCT number | NCT00119600 |
|---|---|
| Title | A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy |
| Official title | A Randomised, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Finding Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy |
| Lead sponsor | Amgen, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Cancer |
| Intervention type | Drug |
| Interventions | AMG 114 |
| First posted | Jul 14, 2005 |
| Last update posted | May 11, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: